NYSE:MJN - Mead Johnson Nutrition Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$89.98
+0.30 (1.20%)
Get New Mead Johnson Nutrition Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MJN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MJN

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Mead Johnson Nutrition in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $89.98.

This chart shows the closing price for MJN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Mead Johnson Nutrition. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/21/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/20/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/19/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/15/2017BMO Capital MarketsReiterated RatingHold$90.00Low
4/3/2017Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$89.00Low
4/1/2017Susquehanna BancsharesSet Price TargetHold$78.00 ➝ $90.00Low
3/6/2017CitigroupDowngradeBuy ➝ NeutralN/A
3/5/2017Credit Suisse GroupDowngradeOutperform ➝ Neutral$90.00N/A
2/13/2017William BlairDowngradeOutperform ➝ Market PerformN/A
2/10/2017BMO Capital MarketsDowngradeOutperform ➝ Market Perform$84.00 ➝ $90.00N/A
2/7/2017UBS GroupBoost Price TargetNeutral$72.00 ➝ $85.00N/A
2/2/2017Berenberg BankUpgradeSell ➝ Hold$66.00N/A
(Data available from 1/19/2017 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/22/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/21/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/21/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/20/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/20/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/19/2022

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Mead Johnson Nutrition logo
Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children's milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company's Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company marketed its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe, as of December 31, 2016.
Read More

Today's Range

Now: $89.98
Low: $89.98
High: $89.98

50 Day Range

MA: N/A

52 Week Range

Now: $89.98
Low: $69.25
High: $94.40

Volume

N/A

Average Volume

3,238,250 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Mead Johnson Nutrition?

The following Wall Street sell-side analysts have issued research reports on Mead Johnson Nutrition in the last twelve months:
View the latest analyst ratings for MJN.

What is the current price target for Mead Johnson Nutrition?

0 Wall Street analysts have set twelve-month price targets for Mead Johnson Nutrition in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Mead Johnson Nutrition in the next year.
View the latest price targets for MJN.

What is the current consensus analyst rating for Mead Johnson Nutrition?

Mead Johnson Nutrition currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MJN.

What other companies compete with Mead Johnson Nutrition?

How do I contact Mead Johnson Nutrition's investor relations team?

Mead Johnson Nutrition's physical mailing address is 225 N Canal St Fl 25, CHICAGO, IL 60606-1791, United States. The company's listed phone number is +1-312-4665800. The official website for Mead Johnson Nutrition is www.meadjohnson.com.